Zoetis Inc. (ZTS)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
161.15+0.19 (+0.12%)
As of 2:38PM EST. Market open.
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 160.96 |
| Open | 161.43 |
| Bid | 161.06 x 900 |
| Ask | 161.12 x 800 |
| Day's Range | 159.65 - 161.80 |
| 52 Week Range | 90.14 - 176.64 |
| Volume | 1,127,060 |
| Avg. Volume | 1,701,417 |
| Market Cap | 76.589B |
| Beta (5Y Monthly) | 0.68 |
| PE Ratio (TTM) | 46.44 |
| EPS (TTM) | 3.47 |
| Earnings Date | Feb 16, 2021 |
| Forward Dividend & Yield | 1.00 (0.62%) |
| Ex-Dividend Date | Jan 19, 2021 |
| 1y Target Est | 185.00 |
- TheStreet.com
Zoetis Could Rally Further After Some More Sideways Consolidation
For his second "Executive Decision" segment of Wednesday night's Mad Money program, Jim Cramer spoke with Kristin Peck, CEO of Zoetis , the drug maker specializing in pets. Peck explained that with the pandemic, pet adoption has risen by 15%, and with so many people spending more time with their pets, they're noticing their pets' medical needs more than ever. Zoetis has over 200 product lines across eight species.
- Zacks
GRFS or ZTS: Which Is the Better Value Stock Right Now?
GRFS vs. ZTS: Which Stock Is the Better Value Option?
- Business Wire
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2020 Financial Results
Zoetis will report Q4 and full year 2020 financial results on Tuesday, Feb 16, 2021.
© 2021 Verizon Media. All rights reserved.
